cbdMD, Inc.
YCBD
$0.74
$0.000.48%
AMEX
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 5.02M | 4.72M | 4.61M | 4.75M | 5.11M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 5.02M | 4.72M | 4.61M | 4.75M | 5.11M |
| Cost of Revenue | 2.02M | 1.94M | 1.78M | 1.79M | 1.71M |
| Gross Profit | 3.00M | 2.78M | 2.83M | 2.96M | 3.40M |
| SG&A Expenses | 2.97M | 2.97M | 3.12M | 3.02M | 2.88M |
| Depreciation & Amortization | 245.40K | 262.10K | 280.20K | 285.90K | 298.00K |
| Other Operating Expenses | 72.80K | 217.00K | 322.80K | 132.60K | 306.40K |
| Total Operating Expenses | 5.30M | 5.41M | 5.51M | 5.24M | 5.20M |
| Operating Income | -286.30K | -685.80K | -904.70K | -485.80K | -86.30K |
| Income Before Tax | -283.10K | -680.00K | -895.30K | -480.80K | 15.10K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -283.10K | -680.00K | -895.30K | -480.80K | 15.10K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -283.10K | -680.00K | -895.30K | -480.80K | 15.10K |
| EBIT | -286.30K | -685.80K | -904.70K | -485.80K | -86.30K |
| EBITDA | -40.80K | -423.80K | -624.50K | -199.90K | 211.70K |
| EPS Basic | -0.04 | -0.08 | -0.21 | -1.90 | -1.73 |
| Normalized Basic EPS | -0.02 | -0.05 | -0.10 | -0.38 | -0.08 |
| EPS Diluted | -0.04 | -0.08 | -0.21 | -1.90 | -1.73 |
| Normalized Diluted EPS | -0.02 | -0.05 | -0.10 | -0.38 | -0.08 |
| Average Basic Shares Outstanding | 9.00M | 8.96M | 5.78M | 778.40K | 569.00K |
| Average Diluted Shares Outstanding | 9.00M | 8.96M | 5.78M | 778.40K | 569.00K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |